Can We Afford the New Era of Lung Cancer Survival?
Published: | Updated:
Durvalumab boosts survival in limited-stage SCLC, yet US costs miss value thresholds, fueling urgent debates on access and pricing.
Chinmay Jani, MD
Chinmay Jani, MD, is a chief fellow, Hematology Oncology, Sylvester Comprehensive Cancer Center.
Articles by Chinmay Jani, MD
Latest Updated Articles
Can We Afford the New Era of Lung Cancer Survival?Published: February 19th 2026 | Updated: February 23rd 2026